Growth Metrics

Voyager Therapeutics (VYGR) Gains from Investment Securities (2016 - 2026)

Voyager Therapeutics' Gains from Investment Securities history spans 11 years, with the latest figure at -$62000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 93.75% to -$62000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$159000.0, a 93.33% increase, with the full-year FY2025 number at $9.6 million, up 9.24% from a year prior.
  • Gains from Investment Securities hit -$62000.0 in Q4 2025 for Voyager Therapeutics, down from $926636.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for VYGR hit a ceiling of $10.3 million in Q2 2025 and a floor of -$2.3 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged $2.7 million across 5 years, with a median of $1.4 million in 2021.
  • Biggest five-year swings in Gains from Investment Securities: surged 6043.15% in 2024 and later crashed 100.34% in 2025.
  • Tracing VYGR's Gains from Investment Securities over 5 years: stood at $1.4 million in 2021, then plummeted by 264.03% to -$2.3 million in 2022, then surged by 98.49% to -$35000.0 in 2023, then rose by 8.57% to -$32000.0 in 2024, then tumbled by 93.75% to -$62000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for VYGR at -$62000.0 in Q4 2025, $926636.0 in Q3 2025, and $10.3 million in Q2 2025.